Special Issue "Microneedle Patches: Developing Strategies for Delivery"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 August 2015).
Interests: membrane separation; CO2 capture and sequestration
Special Issues and Collections in MDPI journals
Special Issue in Pharmaceutics: Antiviral Drug Delivery
Special Issue in Clean Technologies: CO2 Capture and Sequestration 2020
Microneedle technology for drug delivery has grown significantly in the last 15 years. Microneedles have been shown to be able to deliver a range of drugs, vaccines, and genes, e.g., large molecular weight drugs that are larger than 500 Da. Microneedles are very versatile in delivering either solid or liquid drug formulations. Furthermore, it has been shown that microneedle technology can be combined with other methods, such as ultrasound and iontophoresis. Microneedles have been manufactured from a wide range of materials, such as polymers (e.g., polycarbonates and silk fibroin) and metals (e.g., titanium and stainless steel). Novel techniques of production have also been introduced in the past few decades, which include spatially discrete thermal drawing, centrifuge molding, and laser drilling. Microneedles have a promising prospect to transform drug and vaccine delivery, with the potential to improve mass vaccination programs, and facilitate more controlled drug delivery to delicate areas, such as the eye and neurons, thus eliminating the pain, discomfort, and risks associated with drug delivery via hypodermic needles. In particular, there is a significant amount of interest in the area of insulin delivery, where use of microneedles results in a drug release profile, which better mimics the natural insulin release in the body. The prospect of dose sparing and improved stability of vaccines in the dry form has raised a lot of research interest in vaccine delivery via microneedles. Thus, microneedle technology is an increasingly broad area of research interest. Keeping these facts in mind, the journal Special Issue invites papers on the following areas:
(i) Materials for microneedle systems
(ii) Manufacture of microneedle systems
(iii)Combination of microneedles with other methods
(iv) Pre-clinical and clinical studies using microneedle systems
(v) Modeling and optimization of microneedle systems
(vi) Permeation studies involving microneedle pierced skin.
Dr. Diganta B Das
Dr. Ololade Olatunji
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- permeation study
- modeling and optimization
- materials for microneedles
- manufacturing method